Craig C. Hopkinson
Executive VP of Research & Development and Chief Medical OfficerDr. Craig C. Hopkinson, M.D., was Director of Albireo Pharma, Inc. from December 1, 2022 until March 01, 2023. He has been Chief Medical Officer at Alkermes plc since May 30, 2017 and has been its Executive Vice President of Research & Development since January 2020 and was its Senior Vice President of Clinical Development & Medical Affairs since May 30, 2017 until 2020. Dr. Hopkinson was the Chief Medical Officer and Senior Vice President of Medicines Development and Medical Affairs of Alkermes, Inc. from February 2018 to January 2020, and Chief Medical Officer and Senior Vice President of Clinical Development and Medical Affairs of Alkermes, Inc. from May 2017 to February 2018. Dr. Hopkinson has experience building and leading clinical development organizations and medical affairs groups in the biopharmaceutical industry. He has led multidisciplinary development teams in multiple therapeutic areas, including neuroscience, oncology, gastroenterology, infectious diseases, cardiovascular conditions, inflammation, genetic diseases, hematology, and neurodegenerative diseases and has extensive knowledge of clinical study design and the regulatory landscape. Most recently, Dr. Hopkinson held the position of Senior Vice President and Head of Global Medical Affairs for Vertex Pharmaceuticals. Prior to this role, Dr. Hopkinson held various executive management positions at Eisai Pharmaceuticals, including President of Eisai Value Maximization Systems from January 2013 to July 2014, President and Chief Medical Officer of the Frontier Product Creation Unit from October 2011 to December 2012 and Vice President of Medical Affairs, Oncology. In addition, Dr. Hopkinson served in leadership positions at Elan Pharmaceuticals. He served as Vice President of Medical at Actelion Pharmaceuticals US, Inc. He started his career with Servier Laboratories and has subsequently held various positions within Pfizer pharmaceuticals as Major Markets team Leader for Lipitor, Global lead for Caduet and later as Senior Director and Group Lead for the hypertensive dyslipidemia compounds, Pulmonary Hypertension and Viagra. He has also held positions with Astra Zeneca as a Country Medical Director as well as with Pharmacia. Dr. Hopkinson completed his Bachelor of Medicine and Bachelor of Surgery at the University of the Orange Free State in South Africa.
公司职务
- 公司名称Alkermes plc股票代码ALKS职务Executive VP of Research & Development and Chief Medical Officer共事同僚
- BCBlair C. JacksonPresident, CEO & Director
- RFRichard F. PopsChairman
- JRJoshua ReedSenior VP & CFO
- DJDavid Joseph GaffinExecutive VP, Chief Legal Officer, Chief Compliance Officer & Secretary
- CTChristian Todd NicholsSenior VP & Chief Commercial Officer
- SMShane Martin CookeIndependent Director
- RBRichard Brian GaynorIndependent Director
- BPBrian P. McKeonIndependent Director
